| Jul 25 |
AC Immune’s ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer’s Disease
|
| Jul 16 |
AC Immune Showcasing its Novel Morphomer-Antibody Drug Conjugate (morADC) Platform for the Treatment of Neurodegenerative Diseases at AAIC 2024
|
| Jun 15 |
Here's Why Shareholders May Want To Be Cautious With Increasing AC Immune SA's (NASDAQ:ACIU) CEO Pay Packet
|
| Jun 14 |
RH Posts Mixed Q1 Results, Joins MSC Industrial Direct And Other Big Stocks Moving Lower In Friday's Pre-Market Session
|
| Jun 13 |
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune
|
| Jun 10 |
AC Immune SA (NASDAQ:ACIU): Are Analysts Optimistic?
|
| May 28 |
AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024
|
| May 21 |
Individual investors own 24% of AC Immune SA (NASDAQ:ACIU) shares but private equity firms control 30% of the company
|
